EQL Pharma
2006
FOUNDED
PUBLIC
STATUS
1-10
EMPLOYEES
EQL
STOCK SYMBOL
$1.71
SHARE PRICE
(As of Thursday Closing)
Description
EQL Pharma AB is a pharmaceutical company engaged in developing and selling medicines to pharmacies and hospitals. The products offered by the company include generics and parallel imports.
Primary Industry
Pharmaceuticals
Stock Exchange
SAT
Primary Office
- Traktorvagen 11
- 226 60 Lund
- Sweden
+46 046-12 00 00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore EQL Pharma’s full profile, request a free trial.
EQL Pharma Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $1.10 - $1.75 | $49M | $1.69 | 13.6K | 29.1M |
EQL Pharma Financials Summary
|
In Thousands,
USD |
TTM
31-Dec-2019
|
FY 2019
31-Mar-2019
|
FY 2018
31-Mar-2018
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 40,100 | 37,680 | 33,656 | 24,145 |
| Revenue | 7,156 | 5,552 | 4,064 | 3,291 |
| EBITDA | 697 | 376 | 152 | 597 |
| Net Income | 160 | (169) | (62) | 413 |
| Total Assets | 13,111 | 10,953 | 8,031 | 6,982 |
| Total Debt | 0 | 0 | 0 | 0 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
EQL Pharma Executive Team (1)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Christer Fåhraeus Ph.D | Chief Executive Officer & President |